Page 51 - Noble's TMT Consumer Virtual Equity Conference 2024

Medicine Man Technologies, Inc.

SELECTED FINANCIAL ITEMS SHWZ
(in millions of USD)
CQ2 '23 CQ3 '23 CQ4 '23 CQ1 '24 LTM
Income Statement Key Items
Total Revenue 42.38 46.75 43.32 41.60 174.05
Gross Profit 24.52 21.44 7.03 17.93 70.92
Gross Margin 58% 46% 16% 43% 41%
EBIT 4.96 8.92 (14.44) (2.71) (3.27)
EBIT Margin 12% 19% -33% -7% -2%
Net Income to Common Shareholders (6.61) (0.32) (29.36) (16.05) (52.35)
Net Margin -16% -1% -68% -39% -30%

Balance Sheet Key Items
Total Assets 368.96 370.59 358.14 346.61 346.61
Cash & Short Term Investments 19.87 19.62 19.25 13.15 13.15
% of Assets 5% 5% 5% 4% 4%
Current Assets -Total 66.53 64.38 53.67 46.50 46.50
% of Assets 18% 17% 15% 13% 13%
Total Liabilities 220.91 224.80 238.85 242.73 242.73
% of Assets 60% 61% 67% 70% 70%
Current Liabilities - Total 49.77 50.40 55.46 81.87 81.87
% of Assets 13% 14% 15% 24% 24%
Long Term Debt 148.86 150.88 153.26 130.12 130.12
% of Assets 40% 41% 43% 38% 38%
Total Equity 148.05 145.79 119.29 103.88 103.88
% of Assets 40% 39% 33% 30% 30%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities 2.68 6.95 3.45 (3.70) 9.38
Net Cash Flow - Investing (17.63) (4.74) (1.17) (1.53) (25.07)
Net Cash Flow - Financing (0.35) (2.45) (2.66) (0.86) (6.33)

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets Emerging Growth Consumer / Entertainment / Media Conference